SWOG clinical trial number
SWOG-7841
Phase II-III Comparison of FAM vs DHAD in the Treatment of Advanced Gastric Adenocarcinoma
Closed
Phase
Abbreviated Title
Phase II-III Comparison of FAM vs DHAD in the Treatment of Advanced Gastric Adenocarcinoma
Activated
02/16/1979
Closed
08/25/1982
Publication Information Expand/Collapse
1983
Southwest Oncology Group Phase II-III gastric cancer study: 5-Fluorouracil, Adriamycin, and Mitomycin-C + Vincristine (FAM vs V-FAM) compared to chlorozotocin (CZT), m-AMSA, and Dihydroxyanthracenedione (DHAD) with unimpressive differences.